Kuninobu Kanai

1.0k total citations
24 papers, 622 citations indexed

About

Kuninobu Kanai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biotechnology. According to data from OpenAlex, Kuninobu Kanai has authored 24 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 6 papers in Biotechnology. Recurrent topics in Kuninobu Kanai's work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Research and Treatments (6 papers) and Cancer Cells and Metastasis (5 papers). Kuninobu Kanai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Cancer Research and Treatments (6 papers) and Cancer Cells and Metastasis (5 papers). Kuninobu Kanai collaborates with scholars based in Japan, United States and Norway. Kuninobu Kanai's co-authors include Keiichiro Akamatsu, Masanori Nakanishi, Nobuyuki Yamamoto, Hiroaki Akamatsu, Atsushi Hayata, Yasuhiro Koh, Nahomi Tokudome, Hiroki Ueda, Koichi Sato and Eriko Murakami and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Kuninobu Kanai

22 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuninobu Kanai Japan 10 435 316 98 82 71 24 622
Joshua E. Reuss United States 13 370 0.9× 257 0.8× 51 0.5× 47 0.6× 124 1.7× 54 521
Esmée P. Hoefsmit Netherlands 9 188 0.4× 97 0.3× 123 1.3× 54 0.7× 72 1.0× 14 355
Yosuke Kawashima Japan 11 605 1.4× 339 1.1× 112 1.1× 15 0.2× 77 1.1× 41 721
Shinsuke Shiotsu Japan 11 328 0.8× 276 0.9× 44 0.4× 25 0.3× 53 0.7× 41 459
Idoia Morilla Spain 10 359 0.8× 129 0.4× 181 1.8× 44 0.5× 42 0.6× 18 464
Prakash Neupane United States 12 324 0.7× 156 0.5× 36 0.4× 17 0.2× 100 1.4× 37 466
Kota Iida Japan 11 165 0.4× 113 0.4× 69 0.7× 43 0.5× 116 1.6× 38 441
Jean Michel Picquenot France 8 264 0.6× 61 0.2× 111 1.1× 169 2.1× 74 1.0× 11 598
Barbara Burroni France 9 224 0.5× 109 0.3× 93 0.9× 77 0.9× 77 1.1× 37 447
Won Kyung Cho South Korea 12 207 0.5× 165 0.5× 26 0.3× 63 0.8× 72 1.0× 56 462

Countries citing papers authored by Kuninobu Kanai

Since Specialization
Citations

This map shows the geographic impact of Kuninobu Kanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuninobu Kanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuninobu Kanai more than expected).

Fields of papers citing papers by Kuninobu Kanai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuninobu Kanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuninobu Kanai. The network helps show where Kuninobu Kanai may publish in the future.

Co-authorship network of co-authors of Kuninobu Kanai

This figure shows the co-authorship network connecting the top 25 collaborators of Kuninobu Kanai. A scholar is included among the top collaborators of Kuninobu Kanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuninobu Kanai. Kuninobu Kanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Yuichi, et al.. (2024). Rosai–Dorfman disease differentiated from a posterior mediastinal tumour: a case report. Journal of Surgical Case Reports. 2024(7). rjae455–rjae455.
2.
Sato, Koichi, et al.. (2023). Treatment of refractory localized pulmonary nocardiosis caused by Nocardia mexicana with a combination of medication and surgery. SHILAP Revista de lepidopterología. 11(3). e01098–e01098. 3 indexed citations
3.
Akamatsu, Hiroaki, Shunsuke Teraoka, Masanori Tanaka, et al.. (2023). A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients. Journal of Pain and Symptom Management. 67(3). 204–211.e1. 3 indexed citations
4.
Hayashi, Hidetoshi, M. Okada, Takashi Kijima, et al.. (2020). 1895MO Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma. Annals of Oncology. 31. S1076–S1076. 2 indexed citations
5.
6.
Fujimoto, Nobukazu, Morihito Okada, Takashi Kijima, et al.. (2020). Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study. JTO Clinical and Research Reports. 2(3). 100135–100135. 17 indexed citations
7.
Ikeda, Mio, Yasuhiro Koh, Shunsuke Teraoka, et al.. (2020). Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system. Cancer Medicine. 9(6). 2122–2133. 16 indexed citations
8.
Oyanagi, Jun, Yasuhiro Koh, Koichi Sato, et al.. (2019). Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab. Lung Cancer. 132. 107–113. 47 indexed citations
9.
Ikeda, Mio, Yasuhiro Koh, Shunsuke Teraoka, et al.. (2019). Abstract A032: Clinical significance of vimentin-positive AXL-expressing circulating tumor cells in advanced non-small-cell lung cancer patients. Molecular Cancer Therapeutics. 18(12_Supplement). A032–A032. 1 indexed citations
10.
Koh, Yasuhiro, Hiroaki Akamatsu, Kuninobu Kanai, et al.. (2019). Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer. Clinical Lung Cancer. 20(4). 270–277.e1. 37 indexed citations
11.
Kanai, Kuninobu, Nobuyuki Yamamoto, Naoyuki Nogami, et al.. (2018). 141PD A prospective study of molecular testing status in the EGFR mutation positive NSCLC patients with disease progression during EGFR TKI treatment (REMEDY study). Journal of Thoracic Oncology. 13(4). S82–S83. 4 indexed citations
12.
Nakano, Takashi, M. Okada, Takashi Kijima, et al.. (2018). OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study). Journal of Thoracic Oncology. 13(10). S338–S338. 6 indexed citations
13.
Koh, Yasuhiro, Hiroaki Akamatsu, Kuninobu Kanai, et al.. (2017). Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients. PLoS ONE. 12(6). e0179744–e0179744. 36 indexed citations
14.
Sato, Koichi, Hiroaki Akamatsu, Eriko Murakami, et al.. (2017). Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab. Lung Cancer. 115. 71–74. 310 indexed citations
15.
Kikuchi, Takashi, Hiroaki Akamatsu, Keita Mori, et al.. (2016). Applicability of the Japanese equation for estimating glomerular filtration rate in patients with advanced-stage thoracic cancer. Respiratory Investigation. 54(6). 479–483.
16.
Kanai, Kuninobu, Akira Koarai, Hisatoshi Sugiura, et al.. (2015). Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells. Respiratory Investigation. 53(4). 137–148. 31 indexed citations
17.
Matsunaga, Kazuto, Tsunahiko Hirano, Asako Oka, et al.. (2015). Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe Exacerbations. The Journal of Allergy and Clinical Immunology In Practice. 3(5). 759–764.e1. 50 indexed citations
18.
Matsunaga, Kazuto, Tomohiro Ichikawa, Asako Oka, et al.. (2014). Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline. Respiratory Medicine. 108(7). 976–982. 19 indexed citations
19.
Ichikawa, Tomohiro, Hisatoshi Sugiura, Akira Koarai, et al.. (2014). TLR3 Activation Augments Matrix Metalloproteinase Production through Reactive Nitrogen Species Generation in Human Lung Fibroblasts. The Journal of Immunology. 192(11). 4977–4988. 23 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joshua E. Reuss Breakdown of academic impact, for papers by Esmée P. Hoefsmit Breakdown of academic impact, for papers by Yosuke Kawashima Breakdown of academic impact, for papers by Shinsuke Shiotsu Breakdown of academic impact, for papers by Idoia Morilla Breakdown of academic impact, for papers by Prakash Neupane Breakdown of academic impact, for papers by Kota Iida Breakdown of academic impact, for papers by Jean Michel Picquenot Breakdown of academic impact, for papers by Barbara Burroni Breakdown of academic impact, for papers by Won Kyung Cho
Rankless by CCL
2026